References
- Acikgoz, A., D. Cimrin, and G. Ergor, 2020. Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: A nested case–control study. Eastern Mediterranean Health Journal = La Revue de Sante de la Mediterranee Orientale = al-Majallah al-Sihhiyah li-Sharq al-Mutawassit 26 (7):794–802. https://applications.emro.who.int/emhj/v26/07/1020-3397-2020-2607-794-802-eng.pdf. doi: 10.26719/emhj.20.035.
- Ananthakrishnan, A. N., S.-C. Cheng, T. Cai, A. Cagan, V. S. Gainer, P. Szolovits, S. Y. Shaw, S. Churchill, E. W. Karlson, S. N. Murphy, et al. 2014. Association between reduced plasma 25-hydroxy Vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology 12 (5):821–7. https://linkinghub.elsevier.com/retrieve/pii/S1542356513016443. doi: 10.1016/j.cgh.2013.10.011.
- Andersen, S. W., X.-O. Shu, Q. Cai, N. K. Khankari, M. D. Steinwandel, P. W. Jurutka, W. J. Blot, and W. Zheng, 2017. Total and free circulating Vitamin D and Vitamin D-binding protein in relation to colorectal cancer risk in a prospective study of African Americans. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26 (8):1242–7. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-17-0133. doi: 10.1158/1055-9965.EPI-17-0133.
- Anic, G. M., S. J. Weinstein, A. M. Mondul, S. Männistö, and D. Albanes, 2014. Serum Vitamin D, Vitamin D binding protein, and risk of colorectal cancer. PLoS ONE 9 (7):e102966. doi: 10.1371/journal.pone.0102966.
- Bischoff-Ferrari, H. A., E. Giovannucci, W. C. Willett, T. Dietrich, and B. Dawson-Hughes. 2006. Estimation of optimal serum concentrations of 25-Hydroxyvitamin D for multiple health outcomes. The American Journal of Clinical Nutrition 84 (1):18–28. https://academic.oup.com/ajcn/article/84/1/18/4633029. doi: 10.1093/ajcn/84.1.18.
- Boughanem, H., A. Cabrera-Mulero, P. Hernández-Alonso, M. Clemente-Postigo, F. F. Casanueva, F. J. Tinahones, S. Morcillo, A. B. Crujeiras, and M. Macias-Gonzalez, 2020. Association between variation of circulating 25-OH Vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer. Clinical Epigenetics 12 (1):83. https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-020-00875-9. doi: 10.1186/s13148-020-00875-9.
- Braun, M. M., K. J. Helzlsouer, B. W. Hollis, and G. W. Comstock, 1995. Colon Cancer and Serum Vitamin D metabolite levels 10-17 years prior to diagnosis. American Journal of Epidemiology 142 (6):608–11. https://academic.oup.com/aje/article/53799/Colon. doi: 10.1093/oxfordjournals.aje.a117682.
- Carlberg, C., and A. Muñoz. 2020. An update on Vitamin D signaling and cancer. Seminars in Cancer Biology. doi: 10.1016/j.semcancer.2020.05.018
- Chandler, P. D., J. E. Buring, J. E. Manson, E. L. Giovannucci, M. V. Moorthy, S. Zhang, I.-M. Lee, and J. H. Lin, 2015. Circulating Vitamin D levels and risk of colorectal cancer in women. Cancer Prevention Research (Philadelphia, PA) 8 (8):675–82. http://cancerpreventionresearch.aacrjournals.org/lookup/doi/10.1158/1940-6207.CAPR-14-0470. doi: 10.1158/1940-6207.CAPR-14-0470.
- Cheney, C. P., B. Thorand, C. Huth, K. Berger, A. Peters, V. Seifert-Klauss, M. Kiechle, K. Strauch, and A. S. Quante, 2018. The Association between Serum 25-Hydroxyvitamin D and cancer risk: results from the prospective KORA F4 Study. Oncology Research and Treatment 41 (3):117–21. https://www.karger.com/Article/FullText/485512. doi: 10.1159/000485512.
- Deeks, J. J., J. P. T. Higgins, and D. G. Altman. 2021. “Chapter 10: Analysing Data and Undertaking Meta-Analyses.” In Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021). https://training.cochrane.org/handbook/current/chapter-10 (May 25, 2021).
- Dekker, E., P. J. Tanis, J. L. A. Vleugels, P. M. Kasi, and M. B. Wallace, 2019. Colorectal cancer. The Lancet 394 (10207):1467–80. https://linkinghub.elsevier.com/retrieve/pii/S0140673619323190. doi: 10.1016/S0140-6736(19)32319-0.
- Dou, R., K. Ng, E. L. Giovannucci, J. E. Manson, Z. R. Qian, and S. Ogino, 2016. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. The British Journal of Nutrition 115 (9):1643–60. https://www.cambridge.org/core/product/identifier/S0007114516000696/type/journal_article. doi: 10.1017/S0007114516000696.
- Ekmekcioglu, C., D. Haluza, and M. Kundi, 2017. 25-Hydroxyvitamin D status and risk for colorectal cancer and Type 2 diabetes mellitus: A systematic review and meta-analysis of epidemiological studies. International Journal of Environmental Research and Public Health 14 (2):127. http://www.mdpi.com/1660-4601/14/2/127. doi: 10.3390/ijerph14020127.
- Feldman, D., A. V. Krishnan, S. Swami, E. Giovannucci, and B. J. Feldman, 2014. The Role of Vitamin D in reducing cancer risk and progression. Nature Reviews. Cancer 14 (5):342–57. http://www.nature.com/articles/nrc3691. doi: 10.1038/nrc3691.
- Feskanich, D., J. Ma, C. S. Fuchs, G. J. Kirkner, S. E. Hankinson, B. W. Hollis, and E. L. Giovannucci, 2004. Plasma Vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 13 (9):1502–8.
- Gandini, S., M. Boniol, J. Haukka, G. Byrnes, B. Cox, M. J. Sneyd, P. Mullie, and P. Autier, 2011. Meta-analysis of observational studies of Serum 25-Hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer 128 (6):1414–24. http://doi.wiley.com/10.1002/ijc.25439. doi: 10.1002/ijc.25439.
- Garland, C. F., et al. 1989. Serum 25-Hydroxy Vitamin D and colon cancer: eight-year prospective study. The Lancet 334 (8673):1176–8. https://linkinghub.elsevier.com/retrieve/pii/S0140673689917893.
- Garland, C. F., and F. C. Garland, 1980. Do Sunlight and Vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology 9 (3):227–31. https://academic.oup.com/ije/article-lookup/doi/10.1093/ije/9.3.227. doi: 10.1093/ije/9.3.227.
- Garland, C. F., and E. D. Gorham, 2017. Dose-Response of Serum 25-Hydroxyvitamin D in association with risk of colorectal cancer: a meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology 168:1–8. https://linkinghub.elsevier.com/retrieve/pii/S0960076016303429. doi: 10.1016/j.jsbmb.2016.12.003.
- Gorham, E. D., C. F. Garland, F. C. Garland, W. B. Grant, S. B. Mohr, M. Lipkin, H. L. Newmark, E. Giovannucci, M. Wei, M. F. Holick, et al. 2007. Optimal Vitamin D status for colorectal cancer prevention. American Journal of Preventive Medicine 32 (3):210–6. https://linkinghub.elsevier.com/retrieve/pii/S0749379706004983. doi: 10.1016/j.amepre.2006.11.004.
- Grant, W. B. 2010. Relation between prediagnostic serum 25-Hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. Journal of Photochemistry and Photobiology. B, Biology 101 (2):130–6. https://linkinghub.elsevier.com/retrieve/pii/S1011134410001065. doi: 10.1016/j.jphotobiol.2010.04.008.
- Hamling, J., P. Lee, R. Weitkunat, and M. Ambühl, 2008. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Statistics in Medicine 27 (7):954–70. http://doi.wiley.com/10.1002/sim.3013. doi: 10.1002/sim.3013.
- Heath, A. K., A. M. Hodge, P. R. Ebeling, D. Kvaskoff, D. W. Eyles, G. G. Giles, D. R. English, and E. J. Williamson, 2020. Circulating 25-Hydroxyvitamin D concentration and cause-specific mortality in the melbourne collaborative cohort study. The Journal of Steroid Biochemistry and Molecular Biology 198:105612. https://linkinghub.elsevier.com/retrieve/pii/S0960076019304844. doi: 10.1016/j.jsbmb.2020.105612.
- Higgins, J. P. T., and S. Green, eds. 2019. Cochrane handbook for systematic reviews of interventions. United Kingdom: The Cochrane Collaboration.
- Higgins, J., and S. Green, 2015. Cochrane handbook for systematic reviews of interventions Version 5.3.0. Chichester. The Cochrane Collaboration 2 (2):126–30. www.cochrane-handbook.org.
- Hiraki, L. T., A. D. Joshi, K. Ng, C. S. Fuchs, J. Ma, A. Hazra, U. Peters, E. W. Karlson, E. Giovannucci, P. Kraft, et al. 2014. Joint effects of colorectal cancer susceptibility loci, circulating 25-Hydroxyvitamin D and risk of colorectal cancer”. PLoS ONE 9 (3):e92212. https://dx.plos.org/10.1371/journal.pone.0092212. doi: 10.1371/journal.pone.0092212.
- Huang, D., S. Lei, Y. Wu, M. Weng, Y. Zhou, J. Xu, D. Xia, E. Xu, M. Lai, H. Zhang, et al. 2020. Additively protective effects of Vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis. Clinical Nutrition (Edinburgh, Scotland) 39 (8):2525–38. https://linkinghub.elsevier.com/retrieve/pii/S0261561419331395. doi: 10.1016/j.clnu.2019.11.012.
- Jenab, M., H. B. Bueno-de-Mesquita, P. Ferrari, F. J. B. van Duijnhoven, T. Norat, T. Pischon, E. H. J. M. Jansen, N. Slimani, G. Byrnes, S. Rinaldi, et al. 2010. Association between pre-diagnostic circulating Vitamin D concentration and risk of colorectal cancer in European Populations: A nested case-control study. BMJ (Clinical Research ed.) 340 (jan21 3):b5500–b5500. https://www.bmj.com/lookup/doi/10.1136/bmj.b5500. doi: 10.1136/bmj.b5500.
- Keum, N. N. a., and E. Giovannucci, 2019. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology 16 (12):713–32. http://www.nature.com/articles/s41575-019-0189-8. doi: 10.1038/s41575-019-0189-8.
- Lee, J. E., H. Li, A. T. Chan, B. W. Hollis, I.-M. Lee, M. J. Stampfer, K. Wu, E. Giovannucci, and J. Ma, 2011. Circulating levels of Vitamin D and colon and rectal cancer: The physicians' health study and a meta-analysis of prospective studies . Cancer Prevention Research (Philadelphia, PA) 4 (5):735–43. http://cancerpreventionresearch.aacrjournals.org/lookup/doi/10.1158/1940-6207.CAPR-10-0289. doi: 10.1158/1940-6207.CAPR-10-0289.
- Ma, Y., P. Zhang, F. Wang, J. Yang, Z. Liu, and H. Qin, 2011. Association between Vitamin D and risk of colorectal cancer: A systematic review of prospective studies. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29 (28):3775–82. http://ascopubs.org/doi/10.1200/JCO.2011.35.7566. doi: 10.1200/JCO.2011.35.7566.
- McCullough, M. L., et al. 2019. Circulating Vitamin D and colorectal cancer risk: An international pooling project of 17 Cohorts. JNCI: Journal of the National Cancer Institute 111 (2):158–69. https://academic.oup.com/jnci/article/111/2/158/5035027.
- Neuhouser, M. L., J. E. Manson, A. Millen, M. Pettinger, K. Margolis, E. T. Jacobs, J. M. Shikany, M. Vitolins, L. Adams-Campbell, S. Liu, et al. 2012. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. American Journal of Epidemiology 175 (7):673–84. https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwr350. doi: 10.1093/aje/kwr350.
- NHLBI. 2014. Quality assessment tool for observational cohort and cross-sectional studies, 1–4. Bethesda, MD: National Institutes of Health, Department of Health and Human Services. https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort.
- Nurminen, V., A. Neme, J. Ryynänen, S. Heikkinen, S. Seuter, and C. Carlberg, 2015. The transcriptional regulator BCL6 participates in the secondary gene regulatory response to Vitamin D. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849 (3):300–8. https://linkinghub.elsevier.com/retrieve/pii/S1874939914002958. doi: 10.1016/j.bbagrm.2014.12.001.
- Ordóñez-Mena, J. M., B. Schöttker, V. Fedirko, M. Jenab, A. Olsen, J. Halkjaer, E. Kampman, L. de Groot, E. Jansen, H. B. Bueno-de-Mesquita, et al. 2016. Pre-Diagnostic Vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES Consortium. European Journal of Epidemiology 31 (3):311–23. http://link.springer.com/10.1007/s10654-015-0040-7. doi: 10.1007/s10654-015-0040-7.
- Ordóñez-Mena, J. M., B. Schöttker, U. Haug, H. Müller, J. Köhrle, L. Schomburg, B. Holleczek, and H. Brenner, 2013. Serum 25-Hydroxyvitamin D and cancer risk in older adults: Results from a large German prospective cohort study. Cancer Epidemiology Biomarkers & Prevention 22 (5):905–16. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-12-1332. doi: 10.1158/1055-9965.EPI-12-1332.
- Otani, T., for the Japan Public Health Center-Based Prospective Study Group, M. Iwasaki, S. Sasazuki, M. Inoue, and S. Tsugane, 2007. Plasma Vitamin D and risk of colorectal cancer: The Japan public health center-based prospective study. British Journal of Cancer 97 (3):446–51. http://www.nature.com/articles/6603892. doi: 10.1038/sj.bjc.6603892.
- Pludowski, P., M. F. Holick, W. B. Grant, J. Konstantynowicz, M. R. Mascarenhas, A. Haq, V. Povoroznyuk, N. Balatska, A. P. Barbosa, T. Karonova, et al. 2018. Vitamin D supplementation guidelines. The Journal of Steroid Biochemistry and Molecular Biology 175:125–35. https://pubmed.ncbi.nlm.nih.gov/28216084/ (May 26, 2021). doi: 10.1016/j.jsbmb.2017.01.021.
- Siegel, Rebecca, L., et al. 2020. Colorectal cancer statistics, 2020. CA: A Cancer Journal for Clinicians 70 (3):145–64. https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21601.
- Skaaby, T., L. L. N. Husemoen, B. H. Thuesen, C. Pisinger, T. Jørgensen, N. Roswall, S. C. Larsen, and A. Linneberg, 2014. Prospective population-based study of the association between serum 25-Hydroxyvitamin-D Levels and the incidence of specific types of cancer. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 23 (7):1220–9. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-14-0007. doi: 10.1158/1055-9965.EPI-14-0007.
- Song, M., G. G. Konijeti, C. Yuan, A. N. Ananthakrishnan, S. Ogino, C. S. Fuchs, E. L. Giovannucci, K. Ng, and A. T. Chan, 2016. Plasma 25-Hydroxyvitamin D, Vitamin D binding protein, and risk of colorectal cancer in the nurses' health study. Cancer Prevention Research (Philadelphia, PA) 9 (8):664–72. http://cancerpreventionresearch.aacrjournals.org/lookup/doi/10.1158/1940-6207.CAPR-16-0053. doi: 10.1158/1940-6207.CAPR-16-0053.
- Song, M., K. Wu, A. T. Chan, C. S. Fuchs, and E. L. Giovannucci, 2014. Plasma 25-Hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 23 (10):2175–80. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-14-0712. doi: 10.1158/1055-9965.EPI-14-0712.
- Stroup, D. F., J. A. Berlin, S. C. Morton, I. Olkin, G. D. Williamson, D. Rennie, D. Moher, B. J. Becker, T. A. Sipe, and S. B. Thacker, 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 (15):2008–12. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.283.15.2008. doi: 10.1001/jama.283.15.2008.
- Swanson, C. M., Osteoporotic Fractures in Men MrOS Study Research Group, P. Srikanth, C. G. Lee, S. R. Cummings, I. Jans, J. A. Cauley, R. Bouillon, D. Vanderschueren, E. S. Orwoll, and C. M. Nielson, 2015. Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D with bone mineral density, bone mineral density change, and incident nonvertebral fracture. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 30 (8):1403–13. http://doi.wiley.com/10.1002/jbmr.2487. doi: 10.1002/jbmr.2487.
- Tangrea, J., K. Helzlsouer, P. Pietinen, P. Taylor, B. Hollis, J. Virtamo, and D. Albanes, 1997. Serum Levels of Vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes and Control 8 (4):615–25. doi: 10.1023/A:1018450531136.
- Theodoratou, E., T. Palmer, L. Zgaga, S. M. Farrington, P. McKeigue, F. V. N. Din, A. Tenesa, G. Davey-Smith, M. G. Dunlop, and H. Campbell, 2012. Instrumental variable estimation of the causal effect of plasma 25-Hydroxy-Vitamin D on colorectal cancer risk: A Mendelian randomization analysis. PLoS One 7 (6):e37662. doi: 10.1371/journal.pone.0037662.
- Touvier, M., D. S. M. Chan, R. Lau, D. Aune, R. Vieira, D. C. Greenwood, E. Kampman, E. Riboli, S. Hercberg, and T. Norat, 2011. Meta-analyses of Vitamin D intake, 25-Hydroxyvitamin D Status, Vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 20 (5):1003–16. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-10-1141. doi: 10.1158/1055-9965.EPI-10-1141.
- Vojdeman, F. J., C. M. Madsen, K. Frederiksen, D. Durup, A. Olsen, L. Hansen, A.-M. Heegaard, B. Lind, A. Tjønneland, H. L. Jørgensen, et al. 2019. Vitamin D Levels and cancer incidence in 217,244 individuals from primary health care in Denmark. International Journal of Cancer 145 (2):338–46. https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32105. doi: 10.1002/ijc.32105.
- Weinstein, S. J., et al. 2015. Serum 25-Hydroxyvitamin D, Vitamin D binding protein and risk of colorectal cancer in the prostate, lung, colorectal and ovarian cancer screening trial. International Journal of Cancer 136 (6):E654–64. http://doi.wiley.com/10.1002/ijc.29157.
- Weinstein, S. J., K. Yu, R. L. Horst, J. Ashby, J. Virtamo, and D. Albanes, 2011. Serum 25-Hydroxyvitamin D and risks of colon and rectal cancer in Finnish Men. American Journal of Epidemiology 173 (5):499–508. https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwq398. doi: 10.1093/aje/kwq398.
- Wells, G. A., B. Shea, D. O’Connell, and J. Peterson. 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- Wesselink, E., M. Balvers, M. J. L. Bours, J. H. W. de Wilt, R. F. Witkamp, H. van Baar, A. J. M. R. Geijsen, H. van Halteren, E. T. P. Keulen, D. E. Kok, et al. 2020. The association between circulating levels of Vitamin D and inflammatory markers in the first 2 years after colorectal cancer diagnosis. Therapeutic Advances in Gastroenterology 13:1756284820923922. http://journals.sagepub.com/doi/10.1177/1756284820923922. doi: 10.1177/1756284820923922.
- Wimalawansa, S. J. 2019. Vitamin D deficiency: effects on oxidative stress, epigenetics. Gene Regulation, and Aging. Biology 8 (2):30. https://www.mdpi.com/2079-7737/8/2/30. doi: 10.3390/biology8020030.
- Wong, Y. Y. E., Z. Hyde, K. A. McCaul, B. B. Yeap, J. Golledge, G. J. Hankey, and L. Flicker, 2014. In older men, lower plasma 25-Hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer” ed. Suminori Akiba. PLoS One 9 (6):e99954. https://dx.plos.org/10.1371/journal.pone.0099954. doi: 10.1371/journal.pone.0099954.
- Woolcott, C. G., L. R. Wilkens, A. M. Y. Nomura, R. L. Horst, M. T. Goodman, S. P. Murphy, B. E. Henderson, L. N. Kolonel, and L. Le Marchand, 2010. Plasma 25-Hydroxyvitamin D levels and the risk of colorectal cancer: The multiethnic cohort study. Cancer Epidemiology Biomarkers & Prevention 19 (1):130–4. http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EPI-09-0475. doi: 10.1158/1055-9965.EPI-09-0475.
- Wu, K., D. Feskanich, C. S. Fuchs, A. T. Chan, W. C. Willett, B. W. Hollis, M. N. Pollak, and E. Giovannucci, 2011. Interactions between plasma levels of 25-Hydroxyvitamin D, Insulin-like Growth Factor (IGF)-1 and C-peptide with risk of colorectal cancer.” ed. Libing Song. PloS One 6 (12):e28520. https://dx.plos.org/10.1371/journal.pone.0028520. doi: 10.1371/journal.pone.0028520.
- Wu, K., D. Feskanich, C. S. Fuchs, W. C. Willett, B. W. Hollis, and E. L. Giovannucci, 2007. A Nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. Journal of the National Cancer Institute 99 (14):1120–9. https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djm038. doi: 10.1093/jnci/djm038.
- Yin, L., N. Grandi, E. Raum, U. Haug, V. Arndt, and H. Brenner, 2009. Meta-analysis: Longitudinal studies of serum Vitamin D and colorectal cancer risk. Alimentary Pharmacology & Therapeutics 30 (2):113–25. http://doi.wiley.com/10.1111/j.1365-2036.2009.04022.x. doi: 10.1111/j.1365-2036.2009.04022.x.
- Ying, H.-Q., H.-L. Sun, B.-S. He, Y.-Q. Pan, F. Wang, Q.-W. Deng, J. Chen, X. Liu, and S.-K. Wang, 2015. Circulating Vitamin D binding protein, total, free and bioavailable 25-Hydroxyvitamin D and risk of colorectal cancer. Scientific Reports 5 (1):7956. http://www.nature.com/articles/srep07956. doi: 10.1038/srep07956.
- Zhu, K. M., Knuiman, M. Divitini, J. Hung, E. M. Lim, B. R. Cooke, and J. P. Walsh, 2019. Lower Serum 25-Hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study. Nutrition Research 67:100–7. https://linkinghub.elsevier.com/retrieve/pii/S0271531718309291. doi: 10.1016/j.nutres.2019.03.010.